Oflofine M Oral Suspension Tangy Orange is a combination antibiotic formulation containing Ofloxacin 50 mg and Metronidazole 100 mg per dose, designed for oral administration. Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication and transcription. Metronidazole, a nitroimidazole antibiotic, is effective against anaerobic bacteria and certain protozoa by disrupting DNA synthesis through the formation of toxic metabolites. This synergistic combination targets a wide range of aerobic and anaerobic pathogens, making Oflofine M suitable for treating mixed infections such as gastrointestinal infections, dental infections, respiratory tract infections, and skin and soft tissue infections. The tangy orange flavor enhances palatability, facilitating adherence in pediatric and adult patients who require suspension formulations. Oflofine M should be used according to prescribed dosages and duration to minimize the risk of resistance development. Caution is advised in patients with known hypersensitivity to fluoroquinolones or nitroimidazoles, and it is contraindicated in the first trimester of pregnancy. Common adverse effects may include gastrointestinal disturbances, headache, and dizziness. Patients should be monitored for any signs of hypersensitivity or neurological symptoms during therapy.